Cross Operating Cash Flow Sales Ratio from 2010 to 2024

CCRN Stock  USD 18.15  6.99  62.63%   
Cross Country Operating Cash Flow Sales Ratio yearly trend continues to be very stable with very little volatility. Operating Cash Flow Sales Ratio is likely to grow to 0.13 this year. During the period from 2010 to 2024, Cross Country Operating Cash Flow Sales Ratio quarterly data regression pattern had sample variance of  0 and median of  0.03. View All Fundamentals
 
Operating Cash Flow Sales Ratio  
First Reported
2010-12-31
Previous Quarter
0.12303538
Current Value
0.13
Quarterly Volatility
0.0471326
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cross Country financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cross Country's main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.6 M, Interest Expense of 5.9 M or Selling General Administrative of 318.6 M, as well as many indicators such as Price To Sales Ratio of 0.75, Dividend Yield of 2.0E-4 or PTB Ratio of 1.59. Cross financial statements analysis is a perfect complement when working with Cross Country Valuation or Volatility modules.
  
Check out the analysis of Cross Country Correlation against competitors.

Latest Cross Country's Operating Cash Flow Sales Ratio Growth Pattern

Below is the plot of the Operating Cash Flow Sales Ratio of Cross Country Healthcare over the last few years. It is Cross Country's Operating Cash Flow Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cross Country's overall financial position and show how it may be relating to other accounts over time.
Operating Cash Flow Sales Ratio10 Years Trend
Pretty Stable
   Operating Cash Flow Sales Ratio   
       Timeline  

Cross Operating Cash Flow Sales Ratio Regression Statistics

Arithmetic Mean0.04
Geometric Mean0.03
Coefficient Of Variation118.82
Mean Deviation0.03
Median0.03
Standard Deviation0.05
Sample Variance0
Range0.1811
R-Value0.23
Mean Square Error0
R-Squared0.05
Significance0.41
Slope0
Total Sum of Squares0.03

Cross Operating Cash Flow Sales Ratio History

2024 0.13
2023 0.12
2022 0.0478
2021 -0.0511
2020 0.0325
2019 0.00674
2018 0.0257

About Cross Country Financial Statements

Cross Country investors utilize fundamental indicators, such as Operating Cash Flow Sales Ratio, to predict how Cross Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Operating Cash Flow Sales Ratio 0.12  0.13 

Pair Trading with Cross Country

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cross Country position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cross Country will appreciate offsetting losses from the drop in the long position's value.

Moving together with Cross Stock

  0.75CI Cigna CorpPairCorr

Moving against Cross Stock

  0.88ELMD ElectromedPairCorr
  0.86MD Mednax IncPairCorr
  0.86ECOR Electrocore LLCPairCorr
  0.78DOCS DoximityPairCorr
  0.75VREX Varex Imaging CorpPairCorr
The ability to find closely correlated positions to Cross Country could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cross Country when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cross Country - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cross Country Healthcare to buy it.
The correlation of Cross Country is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cross Country moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cross Country Healthcare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cross Country can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Cross Country Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cross Country's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cross Country Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cross Country Healthcare Stock:
Check out the analysis of Cross Country Correlation against competitors.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cross Country. If investors know Cross will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cross Country listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.79)
Earnings Share
(0.05)
Revenue Per Share
42.699
Quarterly Revenue Growth
(0.29)
Return On Assets
0.0127
The market value of Cross Country Healthcare is measured differently than its book value, which is the value of Cross that is recorded on the company's balance sheet. Investors also form their own opinion of Cross Country's value that differs from its market value or its book value, called intrinsic value, which is Cross Country's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cross Country's market value can be influenced by many factors that don't directly affect Cross Country's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cross Country's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cross Country is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cross Country's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.